State of Wyoming Has $307,000 Stock Position in Astera Labs, Inc. $ALAB

State of Wyoming grew its position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) by 239.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,801 shares of the company’s stock after buying an additional 1,975 shares during the quarter. State of Wyoming’s holdings in Astera Labs were worth $307,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Atreides Management LP grew its position in Astera Labs by 2,496.6% during the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after acquiring an additional 1,549,144 shares during the last quarter. Amundi raised its position in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Artisan Partners Limited Partnership acquired a new position in Astera Labs in the fourth quarter worth $148,980,000. Goldman Sachs Group Inc. boosted its stake in Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares in the last quarter. Finally, State Street Corp grew its holdings in shares of Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $1,577,250.00. Following the transaction, the director owned 57,466 shares of the company’s stock, valued at approximately $25,859,700. This trade represents a 5.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 1,676,845 shares of company stock worth $444,928,806. Corporate insiders own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ALAB shares. Needham & Company LLC raised their target price on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Citigroup lowered shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Stifel Nicolaus boosted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Finally, Roth Capital reaffirmed a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $282.00.

View Our Latest Research Report on ALAB

Astera Labs Stock Performance

NASDAQ ALAB opened at $282.52 on Tuesday. The stock has a market capitalization of $48.43 billion, a P/E ratio of 190.89, a price-to-earnings-growth ratio of 3.38 and a beta of 3.66. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The stock has a fifty day moving average of $360.28 and a 200-day moving average of $226.92.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.